These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. T-cell receptor gene therapy for cancer: the progress to date and future objectives. Thomas S; Hart DP; Xue SA; Cesco-Gaspere M; Stauss HJ Expert Opin Biol Ther; 2007 Aug; 7(8):1207-18. PubMed ID: 17696819 [TBL] [Abstract][Full Text] [Related]
4. Finding suitable targets is the major obstacle to cancer gene therapy. Rosenberg SA Cancer Gene Ther; 2014 Feb; 21(2):45-7. PubMed ID: 24535159 [No Abstract] [Full Text] [Related]
6. Cancer gene therapy: present status and future directions. Nabel GJ Ernst Schering Res Found Workshop; 2003; (43):81-8. PubMed ID: 12894452 [No Abstract] [Full Text] [Related]
7. [Adoptive immunotherapy for cancer with genetically engineered T cells]. Ikeda H; Okamoto S; Mineno J; Imai N; Ito M; Yasukawa M; Takesako K; Shiku H Rinsho Ketsueki; 2010 Nov; 51(11):1647-53. PubMed ID: 21157127 [No Abstract] [Full Text] [Related]
9. Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation. Cieri N; Mastaglio S; Oliveira G; Casucci M; Bondanza A; Bonini C Immunol Rev; 2014 Jan; 257(1):165-80. PubMed ID: 24329796 [TBL] [Abstract][Full Text] [Related]
10. Adoptive cell transfer of T-cell receptor-engineered lymphocytes: lessons from recent modeling. Ribas A; Koya RC Future Oncol; 2010 Nov; 6(11):1671-3. PubMed ID: 21142653 [No Abstract] [Full Text] [Related]
11. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy. Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878 [TBL] [Abstract][Full Text] [Related]
12. [Current status and future prospects of gene therapy]. Ozawa K Nihon Ronen Igakkai Zasshi; 1999 Oct; 36(10):690-4. PubMed ID: 10614121 [No Abstract] [Full Text] [Related]
13. Cancer gene therapy annual conference 1997: trends and news. Paillard F Hum Gene Ther; 1998 Feb; 9(3):283-6. PubMed ID: 9508045 [No Abstract] [Full Text] [Related]
14. Enhanced T cell receptor gene therapy for cancer. Kieback E; Uckert W Expert Opin Biol Ther; 2010 May; 10(5):749-62. PubMed ID: 20201709 [TBL] [Abstract][Full Text] [Related]
15. T-cell engineering for cancer immunotherapy. Sadelain M Cancer J; 2009; 15(6):451-5. PubMed ID: 20010162 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy: into the future of surgery. Hollingsworth SJ; Barker SG Lancet; 1999 Apr; 353 Suppl 1():SI19-20. PubMed ID: 10319927 [No Abstract] [Full Text] [Related]